Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 6Phase 4 1Phase 2/3 1

Status

Completed 47Unknown 9Terminated 9Recruiting 7Active not recruiting 7Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 3Sarcoma 2Dermatologic 2

Conditions

Hodgkin Disease 3Sarcoma 1Melanoma 1Leiomyosarcoma 1Hyperthermia 1Advanced Melanoma 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Dacarbazine × Clear all
NCT07310784 2026-05-12

A Phase II Trial of LM103 in Advanced Melanoma

Suzhou BlueHorse Therapeutics Co., Ltd.

Phase 2 Recruiting
92 enrolled
Dermatologic

Advanced Melanoma

NCT06377566 2026-04-23

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
71 enrolled
Lymphoid

Hodgkin Disease

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting
24 enrolled
Sarcoma

Hyperthermia, Sarcoma

NCT06703398 2025-12-23

MIZAR-003

Shanghai Juncell Therapeutics

Phase 2 Recruiting
98 enrolled
Dermatologic

Melanoma

NCT06984146 2025-11-26

Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

National Medical Research Radiological Centre of the Ministry of Health of Russia

Phase 2 Recruiting
54 enrolled
Lymphoid

Hodgkin Disease

NCT07002216 2025-11-03

BrECADD

University of Miami

Phase 2 Recruiting
48 enrolled
Lymphoid

Hodgkin Disease

NCT04535271 2025-02-24

TAGGED

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
80 enrolled
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡